Objective-Intracoronary stenting was designed to overcome acute complications after percutaneous transluminal coronary angioplasty and to achieve a reduced rate of restenosis, both of which are major limitations of this well accepted method for treating coronary heart disease. This report describes the experience at one centre with the implantation of balloon-expandable Palmaz-Schatz stents and focuses on device related complications and the short and long term angiographic outcome.
Although percutaneous transluminal coronary angioplasty (PTCA) is widely accepted as the best intervention for the treatment of coronary heart disease in patients presenting with stable and unstable angina, serious limitations continue despite the progress that has been made. In particular, the incidence of acute complications after balloon angioplasty-such as dissections, vessel rupture, and acute thrombosis with or without consequent myocardial infarction-has been reduced but they remain unpredictable factors.'-5 Furthermore, long term success is limited by the rate of late restenosis, which ranges from 14% to Figure 1 Balloonexpandable Palmaz- following indications: (a) restenosis after an sections); (d) coronary bypass stenosis (one initially successful coronary angioplasty patient). procedure (31 patients); (b) inadequate All patients gave their informed consent for angiographic result after balloon angioplasty the coronary balloon angioplasty procedure, with or without limitation of distal contrast for the stent implantation if at least one of the medium run off (15 patients); (c) bail-out defined indications developed, and for a follow situations (16 patients with symptomatic dis-up coronary angiogram 4-6 months after im- Collaterals  for stenting   1  47  M  H, IIa, N  II  LAD 88  88  LAD S  III  R  2  41  M  IIa, N  I  LAD 89  88  LAD Occ  III  R  3  60  M  -III  LAD87  81  LAD S  II  R,D,B  4  69  M  IIa  III  LAD 87  -RCA Occ  III  R, D, B  5  66  M  IIa, N  I  RCA 88  88  RCA S  II  R, D, B  6  58  M   IIa,N  III  LAD 87  87  LAD S  II  R  7  65  M  -III  -87  RD1 Occ  III  D, B  8  53  M  -II  LAD 88  -LAD S  III  R  9  67  M  N  IV  --RCA S  II  Inad res  10  57  M  H,N  III  LAD88  88  LAD S  III  R  11  55  M  0  III  LAD 88  -LAD S  II  R  12  55  M   0, IIa   II  LAD88  -LAD S  II  R  13  47  M  IIa, N  II  LAD 88  -LAD S  II  R, D, B  14  76  M  O, IIa, N  III  LCx 88  87  LCx S  II  Inad res  15  58  M   0, N   III  LAD 89  88  LAD S  III  R, D, B  16  68  M  IIa, N  I  RIM 89   -RIM S  II  R, D, B  17  68  M  H, IIa, N  III  RCA 86  85  RCA S  II  Inad res  18  55  M  DM, O, N  II  --LAD S  II  D, B  19  64  M   H,0   II  --LAD S  II  D,B  20  70  M   0, IIa, N   III  -89  RCA S  II  D, B  21  64  M   DM, 0, IIa, N   III  LAD 89  -LAD Occ  II  R  22  56  M  N  II  LAD 88  -LAD Occ  III  R, inad res  23  61  M  IIa, N, 0   II  LAD 88  88  LAD S  III  R  24  66  M  N, IIa  III  --RCA Occ  II  Inad res  25  50  M  N  III  LAD 88  88  LAD S  II  R,D, B  26  54  M   IIa, N   III  LAD 88   -LAD S  II  R  27  56  M  N  III  LAD87  -LAD S  II  R  28 Only three of eight patients with multiple stents had patent vessels four to six months after stenting. One had late restenosis and four had late reocclusion. In contrast 28 (85%) of the 33 patients with single stents had patent vessels four to six months after stenting; three Coumarin had been given to 35 of the 41 patients who had long term follow up coronary angiography-seven (20%) with late restenosis or reocclusion and 28 (80%) patients in whom the vessel remained patent. In those not treated with coumarin long term restenosis or reocclusion was found in three patients and long term vessel patency in two (no significant difference compared with the coumarin treated group). One patient in this subgroup died 10 days after implantation.
Discussion
Restenosis after an initial successful coronary angioplasty procedure, inadequate postangioplasty results, coronary venous bypass stenosis, and bail-out situations are commonly accepted indications for stent implantation.'9 21-24 27-32
The rate of successful implantation was 98%, which is comparable to the results of other groups and to the rate of success for pure balloon angioplasty procedures.24293137 Although the balloon with the mounted stent becomes somewhat stiffer, we were able to pass most lesions. The importance of sufficient predilatation was demonstrated in two patients who required another angioplasty before stent delivery was successful. Nevertheless, in tortuous lesions it can be difficult if not impossible to pass the lesion with this device, as occurred in one patient.
Acute complications were less common after stent implantation than after coronary balloon angioplasty. Severe complications such as acute thrombosis or dissections resulting in acute vessel closure were reported in 1 1-8% of patients after coronary balloon angioplasty.5 7 [11] [12] [13] Only one of our patients had acute thrombosis immediately after stent implantation. This patient had unstable angina. The reported rates of thrombosis and acute vessel 
